These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 39220153)

  • 1. Predictive value of coagulation profiles for Kawasaki disease shock syndrome: a prospective cohort study.
    Li B; Liu X; Shao S; Wu P; Wu M; Liu L; Hua Y; Duan H; Zhou K; Wang C
    Front Pediatr; 2024; 12():1450710. PubMed ID: 39220153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of coagulation profiles for both initial and repeated immunoglobulin resistance in Kawasaki disease: A prospective cohort study.
    Shao S; Yang L; Liu X; Liu L; Wu M; Deng Y; Duan H; Li Y; Hua Y; Luo L; Zhou K; Wang C
    Pediatr Allergy Immunol; 2021 Aug; 32(6):1349-1359. PubMed ID: 33694279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Value of the Systemic Immune-Inflammation Index for Intravenous Immunoglobulin Resistance and Cardiovascular Complications in Kawasaki Disease.
    Liu X; Shao S; Wang L; Zhang N; Wu M; Liu L; Zhao L; Hua Y; Zhou K; Luo C; Deng Y; Wang C
    Front Cardiovasc Med; 2021; 8():711007. PubMed ID: 34504878
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study on the value of prothrombin time for predicting the severity and prognosis of septic patients].
    Bai H; Shen L; Jing L; Liu W; Sun Z; Tang N
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jul; 34(7):682-688. PubMed ID: 36100403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition.
    Li Y; Zheng Q; Zou L; Wu J; Guo L; Teng L; Zheng R; Jung LKL; Lu M
    Pediatr Rheumatol Online J; 2019 Jan; 17(1):1. PubMed ID: 30611297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in coagulation indices and
    Gou Y; Yao L; Cao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jul; 48(7):1050-1058. PubMed ID: 37724408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Kawasaki disease shock syndrome in children.
    Zhao Z; Yuan Y; Gao L; Li Q; Wang Y; Zhao S
    Front Immunol; 2024; 15():1400046. PubMed ID: 38887295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and an early predictive model for Kawasaki disease shock syndrome in Chinese children.
    Zhang M; Wang C; Li Q; Wang H; Li X
    Ital J Pediatr; 2024 Feb; 50(1):22. PubMed ID: 38310292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retrospective cohort study on the coagulation characteristics of adult patients with extensively severe burn in shock stage and its alarming value].
    Ma QM; Liu XB; Wu GS; Hou WJ; Fan XM; Shen T; Wang KA; Zhu F
    Zhonghua Shao Shang Za Zhi; 2021 Feb; 37(2):150-156. PubMed ID: 33498103
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
    Wang JR; Zhao HZ; Chang LJ; Xu X; Gao Y; Li M; Kong QY; Wang MM; Zhao CF
    Eur J Pediatr; 2023 Oct; 182(10):4399-4406. PubMed ID: 37480545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease.
    Gamez-Gonzalez LB; Moribe-Quintero I; Cisneros-Castolo M; Varela-Ortiz J; Muñoz-Ramírez M; Garrido-García M; Yamazaki-Nakashimada M
    Pediatr Int; 2018 Sep; 60(9):781-790. PubMed ID: 29888440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changes of coagulation profiles in Kawasaki disease and its associations with clinical classification, intravenous immunoglobulin responsiveness and coronary artery involvement.
    Li DT; Yang Q; Xia CY; Zhang YF; Cai Y; Wu SQ; Jiang Q; Hu P
    Clin Exp Med; 2024 Aug; 24(1):177. PubMed ID: 39105936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestations of Kawasaki disease shock syndrome: a case-control study.
    Chen PS; Chi H; Huang FY; Peng CC; Chen MR; Chiu NC
    J Microbiol Immunol Infect; 2015 Feb; 48(1):43-50. PubMed ID: 23927822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent endothelial damage after intravenous immunoglobulin therapy in Kawasaki disease.
    Sakurai Y; Takatsuka H; Onaka M; Takada M; Nishino M
    Int Arch Allergy Immunol; 2014; 165(2):111-8. PubMed ID: 25401215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An early predictive model for Kawasaki disease shock syndrome in children in central China.
    Wu Y; Yin W; Wen Y; Chen J; Tang H; Ding Y
    Front Cardiovasc Med; 2024; 11():1405012. PubMed ID: 38859816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment and validation of a risk prediction model for disseminated intravascular coagulation patients with electrical burns].
    Li Q; Ba T; Cao SJ; Chen Q; Zhou B; Yan ZQ; Hou ZH; Wang LF
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Aug; 39(8):738-745. PubMed ID: 37805784
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
    Zhang H; Cai J; Zhang R; Shuai S; Tang M; Ju R; Hu Y; Zuo T; Yang Y
    J Int Med Res; 2024 May; 52(5):3000605241252115. PubMed ID: 38713460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kawasaki Disease Shock Syndrome vs Classical Kawasaki Disease: A Meta-analysis and Comparison With SARS-CoV-2 Multisystem Inflammatory Syndrome.
    Lamrani L; Manlhiot C; Elias MD; Choueiter NF; Dionne A; Harahsheh AS; Portman MA; McCrindle BW; Dahdah N
    Can J Cardiol; 2021 Oct; 37(10):1619-1628. PubMed ID: 34090979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive role of sampling-time specific prognostic nutritional index cut-off values for intravenous immunoglobulin resistance and cardiovascular complications in Kawasaki disease.
    Liu X; Shao S; Zhang N; Wu M; Liu L; Duan H; Liu Z; Zhou K; Hua Y; Wang C
    Int Immunopharmacol; 2022 Sep; 110():108986. PubMed ID: 35764015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
    Huang XB; Zhao S; Liu ZY; Xu YY; Deng F
    Ann Med; 2023; 55(2):2264315. PubMed ID: 37870383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.